Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „week“
Suchtreffer
Begriffe & Kennungen
Cymbalta · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Daf
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenDapagliflozin Viatris · 4.8 · 9 a The table shows up to 24-week (short-term) data regardless of glycaemic rescue. b See corresponding subsec
Eintrag öffnenDapagliflozin Viatris · 4.8 · In an add-on to glimepiride study, at weeks 24 and 48, minor episodes of hypoglycaemia were reported more freq
Eintrag öffnenDapagliflozin Viatris · 4.8 · In an add-on to metformin and a sulphonylurea study, up to 24 weeks, no episodes of major hypoglycaemia were r
Eintrag öffnenDarunavir Krka · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Krka · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Krka · 4.8 · Rash In clinical studies, rash was mostly mild to moderate, often occurring within the first four weeks of tre
Eintrag öffnenDarunavir Krka · 4.8 · Rash In clinical studies, rash was mostly mild to moderate, often occurring within the first four weeks of tre
Eintrag öffnenDarunavir Krka · 4.8 · The safety assessment in paediatric patients is based on the 48-week analysis of safety data from three Phase
Eintrag öffnenDarunavir Krka · 4.8 · The safety assessment of darunavir with ritonavir in paediatric patients is based on the 48-week analysis of s
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · In the 96 week analysis, the safety profile of darunavir/ ritonavir 800/100 mg once daily in treatment- naïve
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment- naïve s
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · The safety assessment in paediatric patients is based on the 48-week analysis of safety data from three Phase
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · The safety assessment of darunavir with ritonavir in paediatric patients is based on the 48-week analysis of s
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnen